UK makes final preparations for mass vaccination
The UK will begin a mass vaccination on Tuesday, beginning with the elderly, health workers, and carers
Pfizer
![UK makes final preparations for mass vaccination]()
Covid Pfizer vaccine approved for use next week in UK
Pfizer / BioNTech Covid vaccine approved for use in UK to be rolled out next week.
‘Historic moment’ opens way for mass immunization with first doses to arrive in coming days.![Pfizer BioNTech Covid vaccine approved for use in UK to be rolled out next week. ‘Historic moment’ opens way for mass immunization with first doses to arrive in coming days.]()
Covid: First Americans 'could get vaccine in early December'
The first Americans to receive a Covid-19 vaccine could get it as soon as 11 December, according to the head of the US coronavirus vaccine programme.
![Covid: First Americans 'could get vaccine in early December']()
Pfizer seeking emergency use of its COVID-19 vaccine in US
If the FDA approves, the vaccine will likely be limited and rolled out in phases, with health-care workers, the elderly and people with underlying health conditions getting the first inoculations.
![Pfizer seeking emergency use of its COVID-19 vaccine in US]()
Vaccines that can help India in its fight against Covid-19
The global race to create vaccines against the novel coronavirus has entered a critical stretch, with Pfizer and Moderna releasing very promising final trial data that has raised the hopes of nations struggling to fight the pandemic. Pfizer, which reported 95% efficacy, has now sought early regulatory approval.
![Vaccines that can help India in its fight against Covid-19]()
Pfizer vaccine 'has 95% efficacy and passed safety checks'
Final results from Pfizer Inc’s COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday.
![Pfizer vaccine 'has 95% efficacy and passed safety checks']()
Hopes of Covid vaccine for more than 1bn people by end of 2021
Moderna becomes second firm to reveal positive results with nearly 95% protection in trials.
Vaccine trials 'encouraging' says WHO![Hopes of Covid vaccine for more than 1bn people by end of 2021]()
Covid-19: Normal life back next winter, says vaccine creator
The impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter, one of its creators has said.
- Region:
- World
- Category:
- Technology
- Author/s:
- By Reuters
![Covid-19: Normal life back next winter, says vaccine creator]()
